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Synthetic oligodeoxynucleotides, either unmodified or linked to an intercalating agent, have been used toprevent eDNA elongation by the AMV 
reverse transcriptase. Oligonucleotide/RNA hybrids pecifically arrest primer xtension. The blockage involves the degradation of the RNA part 
bound to the antisense oligonucleotide by the RNase-H activity associated with the retroviral polymerase. 
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1. INTRODUCTION 
Selective inhibit ion of  gene expression can be achiev- 
ed using complementary  nucleic acid sequences, so- 
cal led antisense RNA and DNA.  The expression o f  both 
endogenous and exogenous genes has been specif ical ly 
turned of f  in cell-free systems as well as in micro-  
injected or in cultured cells [1,2]. Chemical ly modi f ied 
o l igodeoxynucleot ides have been synthesized a imed at 
improv ing the eff icacy of  antisense inhibitors ( increased 
resistance to DNases,  improved uptake by intact cells, 
etc.) [3,4]. These compounds  constitute powerfu l  tools 
for molecular  genetics, in part icular  in eukaryot ic  
organisms.  They are also receiving more and more at- 
tent ion as potent ial  therapeut ic  agents [5]. 
Ant isense ol igonucleotides have been targeted to 
tRNA,  rRNA and U snRNA but up to now biological  
studies have been mainly per formed with ol igo- 
nucleotides complementary  to either p re -mRNA or 
mRNAs  [6]. In most cases the o l igonuc leot ide /mRNA 
hybr id  prevented translat ion o f  the message. The in- 
h ib i t ion of  reverse transcr iptase by antisense ol igomers 
can also be envisaged. This can be achieved in 3 dif- 
ferent ways: interact ion with the enzyme, compet i t ion 
with the pr imer,  or arrested elongat ion of  the cDNA 
chain. We investigated the latter possibi l ity. 
The synthesis of  eDNA by reverse transcr iptase could 
be inhibited by an ol igonucleot ide complementary  to a 
region downstream from the pr imer.  In this case the 
stopper  o l igodeoxynucleot ide should have as high an 
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af f in i ty  as possible for its target sequence. 
Oligonucleoticles covalently l inked to an acr idine 
derivat ive have been shown to exhibit a higher aff in i ty 
than homologous unmodi f ied ol igomers for the com- 
p lementary  RNA sequence [7]. We report  here some 
results which show that pr imer extension can be block- 
ed by both unmodi f ied and acr idine- l inked 
ol igonucleot ides.  
2. MATERIALS  AND METHODS 
2.1. Oligonucleotide~ 
Unmodified oligodeoxyribonucleotides 5' d[CACCAACTTCTTC- 
CACA], 5' d[TTGTGTCAAAAGCAAGT] and 5' d[CTGCTACTG- 
GGAGCTTCTCA] were synthesized on a Biosearch synthesizer. 
They will be termed 17-SC, 17-Cap and 20-reed, respectively. They 
were purified in one step by reverse phase HPLC on a Zorbax oligo 
column. A 12-met, 5'(CTGTTCTAATAA), was synthesized ither 
unmodified or linked at its 5' end to 2-methoxy, 6-chloro, 
9-aminoacridine via pentamethylene linker arm, according to a 
previously published procedure [8]. These 12-mers were t rmed 12Tb 
and 12Tb(Acr). Oligomer purity was controlled by electrophoresis, on
a 20070 polyacrylamide/7 M urea gel, of 5' 32p-end-labelled aliquots. 
(12Tb(Acr) was 3'-end-labelled with [32p]c~-ddATP.) Concentrations 
of oligonucleotide solutions were measured byUV absorbance. We 
used a molar extinction coefficient of 8850 M - i. cm - ~ at 425 nm for 
the acridine-linked oligomer. 
2.2. RNAs and enzymes 
T4 polynucleotide kinase was from Boehringer (Mannheim), AMV 
reverse transcriptase, E. coli RNase-H and RNasine were from 
Genofit (Geneva). Rabbit globin mRNA was purchased from 
Bethesda Research Laboratory and was used without reatment. A 
RNA fragment, about 150 nucleotides long, was obtained by 
oligonucleotide-directed leavage of rabbit ~-globin mRNA by E. coil 
RNase-H: 1.25 #g of globin mRNA were incubated, with 12 units of 
E. coli RNase-H, in the presence of 100 pmol of a 15-met complemen- 
tary to nucleotides 147-161 of the/3-globin message. Th  reaction was 
performed for 30 rain at 37°C, in 20 td of a 20 mM Tris-HC1 pH 7.5 
buffer containing 10 mM MgCl2, 100 mM KCI and 0.1 mM 
dithiothreitol. After incubation, RNA was phenol extracted, ethanol 
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Fig. 1. Relative positions of primer and stopper oligonucleotides, (a)
on the rabbit ~-globin mRNA template, and (b) on the mini-exon 
derived RNA from Trypanosoma brucei. The full length cDNA 
products derived from 17-SC (a) and 20-med (b) are indicated below 
the RNAs. Bottom lines schematize truncated fragments resulting 
from the presence of stoppers 17-Cap (a) or 12Tb and 12Tb(Acr) (b). 
Bracketted numbers on the right indicate the expected sizes of DNA 
fragments. 
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precipitated and dissolved in 25/zl of sterile water. Mini-exon derived 
(med) RNA from cultured forms of Trypanosoma brucei was 
prepared according to a previously published procedure [9]. Med- 
RNA from trypanosomes and fragments of rabbit fl-globin mRNA 
were analysed byelectrophoresis on a 8% polyacrylamide/7 M urea 
gel followed by Northern blotting, using 20-med and a 17-mer com- 
plementary tonucleotides 51-67 of/3-globin mRNA as probes, respec- 
tively. 
2.3. Primer extension 
For studies performed with the rabbit /3-globin mRNA, the 
oligomer 17-SC, complementary to region 113-129 of the message 
was used as the primer. Unmodified 17-Cap, targeted to nucleotides 
3-19, was used as stopper (Fig. la). 20-med was used as the primer 
and 12Tb and 12Tb(Acr) were used as stoppers for experiments with 
the mini-exon derived RNA of T. brucei (Fig. lb), the precursor of the 
trans-spliced sequence present on every mRNA of this protozoan 
parasite [10]. For primer extension reactions, 0.9 pmol of RNA, 50 
pmol of primer and the desired amount of stopper oligodeox- 
ynucleotide were pre-heated for 2 rain at 85°C and kept on ice for 30 
min. After addition of 1/zl of 10 x RT buffer (l M Tris-HCl pH, 8.3, 
500 mM KCI, 100 mM MgC12, 100 mM dithiothreitol) containing 8 U 
RNasine, 2 pmol of [32p]u-dATP and 5 nmol of the four dXTPs, the 
volume of the samples was adjusted to 10 #l with sterile H20. AMV 
reverse transcriptase (14 U) was then added and the reaction in- 
cubated for 1 h at 39°C. Reaction was stopped by addition of 1 #l of 
0.5 M EDTA. 
3. RESULTS AND DISCUSSION 
When reverse transcription of rabbit globin mRNA 
was primed by 17-SC a single band corresponding to the 
expected fragment about 130 nucleotides long was ob- 
tained (Fig. 2, lane 1). In contrast, when polymerisation 
was performed in the presence of 15 /zM 17-Cap this 
band was hardly detectable. Instead, two higher mobili- 
ty bands were seen, corresponding to DNA fragments 
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Fig. 2. Effect of 17-Cap on DNA synthesis by AMV reverse 
transcriptase. Primer extension from 17-SC on rabbit /~-globin 
mRNA was performed in the absence (lane 1) or in the presence of 15 
ttM 17-Cap (lane 2). No 17-SC was added to the mixture in lane 3. 
Reaction was performed as indicated in section 2. DNA size markers 
were run in lane M. 
slightly longer than 104 nucleotides (Fig. 2, lane 2). This 
is consistent with the synthesis of a cDNA fragment ex- 
tending from the primer to the 5' end of 17-Cap (Fig. 
la). Therefore the hybridization of this antisense 
oligonucleotide with the complementary sequence of 
the /3-globin mRNA prevents transcription of this 
region. The extent of inhibition was dependent on 
17-Cap concentration; 50°7o reduction of full length 
product was induced by about 0.5/zM of the stopper. 
In addition to the appearance of these short 
fragments, it should be noted that the yield of cDNA 
synthesis was lower in the presence of 17-Cap (lanes 1 
and 2, Fig. 2). This resulted from a competition be- 
tween the primer and the stopper. In the case shown in 
Fig. 2, there was three times more 17-Cap than 17-SC. 
Indeed, the yield of cDNA synthesis varied with the 
overall oligonucleotide concentration. As the lenghten- 
ed 17-Cap escaped etection on our gel this resulted in 
an apparent decrease of reverse transcription. 
The use of oligonucleotides to block reverse 
transcriptase in intact cells will necessitate he penetra- 
tion of the plasmic membrane and a tight binding to the 
target sequence. Additional energy of interaction can be 
provided by covalent linking of an intercalating agent 
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to the end of the oligonucleotide: stacking interactions 
between this agent and base pairs of the hybrid have 
been shown to result in increased stability compared to 
the unmodified oligomer [7,11]. It has also been shown 
that an acridine derivative linked to the end of an 
oligonucleotide promoted its uptake by trypanosomes 
in culture [6]. 
We investigated the effect of acridine-linked 
oligomers on the synthesis of cDNA, by AMV reverse 
transcriptase, from the mini-exon derived RNA of T. 
brucei taken as a model. The mini-exon sequence pre- 
sent at the 5' end of every mRNA of the parasite was 
previously chosen as a target for antisense 
oligonucleotide [12-15]. We transcribed the T. brucei 
med-RNA from a primer located immediately 
downstream of the mini-exon sequence (Fig. lb). The 
synthesis of the full length cDNA fragment (58 
nucleotides) occurred in a very low yield due to the 
presence of a strong pause site at position 27-28, cor- 
responding to the bottom of a strong hairpin structure 
[15]. As shown in Fig. 3, addition of 12Tb(Acr) resulted 
in the appearance of a shorter mini-exon cDNA. The 
length of this DNA fragment (about 40 nucleotides) is
consistent with a block occurring at the binding site of 
12Tb(Acr). However, the level of inhibition was not 
different from that obtained with the homologous un- 
modified oligomer 12Tb. It should be pointed out that 
these oligomers had a 3 ' -OH terminus and could 
therefore be lengthened by the polymerase. Indeed, we 
observed on the gel a band indicating that both 12-mers 
were converted into longer oligomers (about 15 
nucleotides long for the unmodified 12Tb; Fig. 3, lane 
1). The relative contribution of stacking interactions, 
between the acridine residue and base pairs of the 
hybrid, to the overall binding decreases as the 
oligonucleotide l ngth increases [7]. With respect to 
reverse transcriptase inhibition, this very likely ac- 
counts for the similar results obtained with the un- 
modified and acridine-linked 15-mers ynthesized from 
12Tb and 12Tb(Acr). The full length and the truncated 
cDNAs contained 14 and 9 adenine residues, respective- 
ly. Therefore, the actual yield of inhibition was close to 
50°7o as determined from densitometer tracing of lane 1 
(Fig. 3). 
The hybrids formed by primer and stopper 
oligonucleotides with the template RNA are substrates 
for the RNase-H activity associated with the AMV 
polymerase. Of course, cleavage of the RNA region 
bound to the stopper will preclude cDNA synthesis 
beyond the hybridization site. In order to shed some 
light on the mechanism by which antisense 
oligonucleotides block the AMV polymerase, we 
analysed the template RNA after the polymerisation 
reaction. As shown in Fig. 4, incubation of ~-globin 
RNA in the presence of AMV reverse transcriptase, 
17-SC and 17-Cap, led to the appearance of a cleavage 
product whose length was consistent with the attack of 
T 1 2 
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Fig. 3. Effect of 12Tb on DNA synthesis by AMV reverse 
transcriptase. Primer extension from 20-med was performed in the 
absence ofany other complementary oligonucleotide (lane T) or in the 
presence of60/zM 12Tb (lane 1) or 12Tb(Acr) (lane 2). The incubation 
was performed as indicated insection 2. 
the RNA strand, by the polymerase-RNase-H 
associated activity, at the level of the 17-Cap binding 
site. Under the experimental conditions that we used, 
this accounted for the inhibition of cDNA synthesis. 
3.1. Conclusion 
The data presented here unambiguously demonstrate 
that reverse transcription can be selectively inhibited by 
antisense oligomers. Previous reports have already 
shown that oligonucleotide analogues can be used to in- 
terfere with cDNA synthesis. In the case of oligomers 
1 2 
180-  
147-  
110-  
67-  
Fig. 4. Effect of cDNA synthesis inhibition on rabbit globin RNA. i 
Primer extension from 17-SC, on a 150 nucleotide long rabbit B- 
globin mRNA fragment, was performed in the absence (lane 1), or in 
the presence (lane 2) of 17-Cap under the conditions indicated in the 
legend of Fig. 2. Northern blot analysis was carried out as indicated 
in section 2. 
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comprising ot-anomers of nucleoside units, which can- 
not be elongated by reverse transcriptase, inhibition 
was obtained through competition with the primer 
[16,17]. It was also reported that phosphorothiate 
derivatives could prevent HIV development in cultured 
cells by a sequence-independent mechanism involving, 
at least in part, the binding of these modified oligomers 
to the viral reverse transcriptase [18]. The use of cross- 
linking reagents coupled to oligonucleotides to block 
reverse transcriptase has been described; platinum 
derivatives of oligonucleotides were able to stop the ac- 
tivity of reverse transcriptase working on a DNA 
template [19]. However, the reaction to generate cross- 
linked products required overnight incubation. This 
probably precludes the use of such oligomers in 
biological systems (in vitro assays with purified enzyme 
or cultured cells). 
In our case no chemical reaction takes place between 
the stopper oligomer and the target RNA. But, subse- 
quently to the binding of the stopper oligonucleotide, 
the template RNA is permanently modified by the 
RNase-H activity of the viral enzyme. It was reported 
that unmodified oligonucleotides did not block DNA 
synthesis by AMV reverse transcriptase using DNA as a 
template [19]. This supports our conclusion about the 
mechanism of cDNA synthesis inhibition as RNase-H 
cannot cleave such DNA/DNA hybrids. Acridine- 
linked oligonucleotides licit RNase-H activity when 
bound to the complementary RNA sequence [20]. 
Moreover, it has been shown that such modified an- 
tisense oligomers can be used with intact cells, and pre- 
vent the development of the influenza virus [21] and of 
African trypanosomes in culture [14]. Our results in- 
dicate that they might also be of interest in the case of 
retroviruses. 
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